SBRT has non-inferior acute and late-term toxicity vs IMRT in two randomized clinical trials

Posted on February 18, 2019 by Sitemaster

In October 2018, the American Society of Radiation Oncologists (ASTRO) strongly endorsed moderately hypofractionated IMRT (20 or 28 treatments) for primary radiation treatment (see this link). … READ MORE …

Filed under: Uncategorized | Tagged: , , , , | 3 Comments »

Major trial confirms value of zoledronic acid dosed every 3 months in preventing pain, SREs

Posted on June 17, 2015 by Sitemaster

An interesting paper that we managed to miss at the recent annual meeting of the American Society of Clinical Oncology (ASCO) provided the results of a large, randomized clinical trial of the use of zoledronic acid, carried out by the Cancer and Leukemia Group B cooperative trial group. … READ MORE …

Filed under: Living with Prostate Cancer, Management, Prevention, Treatment | Tagged: , , , , , , , | Leave a comment »

  • Donate

  • Disclaimer

    News and information provided on this site should not be used for diagnosing or treating any health problem or disease.

    The “New” Prostate Cancer InfoLink is intended for informational purposes only. It is not engaged in rendering medical advice or professional services and is not a substitute for professional care. If you have or suspect you may have a health problem, please consult your healthcare provider.

  • Hot Posts …

  • … and Archives